Africa Daily Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa Daily Journal.

Press releases published on April 22, 2026

Apr. 22, 2026

Tempest Announces Key Manufacturing Milestone for TPST-2003 Dual-Targeting CD19/BCMA CAR-T

Indeterminate GlobeNewswire

Apr. 22, 2026

Dynacor Provides Expansion and Corporate Update

Indeterminate GlobeNewswire

Apr. 22, 2026

Dynacor offre une mise à jour sur ses projets d’expansion et sur l’entreprise

Indeterminate GlobeNewswire

Apr. 22, 2026

CervoMed Announces New Data at the 2026 AAN Annual Meeting that Demonstrated Neflamapimod Increased Basal Forebrain Volume and Functional Connectivity in Dementia with Lewy Bodies

Indeterminate GlobeNewswire

Apr. 22, 2026

Big Bear Gold Corp. Completes Shares for Debt Settlements

Indeterminate GlobeNewswire

Apr. 22, 2026

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Apr. 22, 2026

Ocular Therapeutix™ to Host Investor Day on June 17, 2026

Indeterminate GlobeNewswire

Apr. 22, 2026

Ligand to Report First Quarter 2026 Financial Results on May 7, 2026

Indeterminate GlobeNewswire

Apr. 22, 2026

Emerita Intersects High Grade Zone of 4.9m Containing Mineralization Grading 3.5% Copper, 1.95 g/t Gold and 95.63 g/t Silver at El Cura

Indeterminate GlobeNewswire

Apr. 22, 2026

From Lab to Field: HPQ and Novacium Secure First Battery Order from European Drone Manufacturer Using GEN4 Cells

Indeterminate GlobeNewswire

Apr. 22, 2026

Du laboratoire au terrain : HPQ et Novacium obtiennent une première commande de batteries auprès d’un fabricant européen de drones utilisant des cellules GEN4

Indeterminate GlobeNewswire

Apr. 22, 2026

OROCO INCREASES ACTIVITY AT SANTO TOMÁS

Indeterminate GlobeNewswire

Apr. 22, 2026

MEXC Secures World's #1 Gold Order Book Depth in Q1 2026

Indeterminate GlobeNewswire

Apr. 22, 2026

Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance

Indeterminate GlobeNewswire

Apr. 22, 2026

AtaiBeckley Announces Additional Phase 2a Results for EMP-01 (oral R-MDMA) Showing Large and Consistent Improvements in Social Anxiety Disorder

Indeterminate GlobeNewswire

Apr. 22, 2026

Fortuna to release first quarter 2026 financial results on May 6, 2026; Conference call at 12 p.m. Eastern time on May 7, 2026

Indeterminate GlobeNewswire

Apr. 22, 2026

Rakovina Therapeutics Presents New Preclinical Data at AACR 2026 Annual Meeting

Indeterminate GlobeNewswire

Apr. 22, 2026

Maze Therapeutics Announces $150 Million Registered Offering

Indeterminate GlobeNewswire